Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Vaccine|February 1, 2003
Immunization with low doses of HIV-1 tat DNA delivered by novel cationic block copolymers induces CTL responses against TatAntonella Caputo, Riccardo Gavioli, Giuseppe Altavilla, et al.
European Journal of Immunology|June 5, 2003
Efficient mucosal delivery of the HIV-1 Tat protein using the synthetic lipopeptide MALP-2 as adjuvantStefan Borsutzky, Valeria Fiorelli, Thomas Ebensen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 29, 2003
Human CD38 interferes with HIV-1 fusion through a sequence homologous to the V3 loop of the viral envelope glycoprotein gp120Andrea Savarino, Thea Bensi, Annalisa Chiocchetti, et al.
FEMS Microbiology Letters|August 23, 2006
Immune response and protection by DNA vaccines expressing antigen 85B of Mycobacterium tuberculosisManuela Pardini, Federico Giannoni, Carla Palma, et al.
International Journal of Molecular Sciences|January 5, 2021
HIV-1 Tat Protein Enters Dysfunctional Endothelial Cells via Integrins and Renders Them Permissive to Virus ReplicationAurelio Cafaro, Giovanni Barillari, Sonia Moretti, et al.
International Immunology|January 17, 2009
NKp44 expression, phylogenesis and function in non-human primate NK cellsAndrea De Maria, Elisabetta Ugolotti, Erik Rutjens, et al.
Nature Medicine|March 5, 2002
HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcomaCecilia Sgadari, Giovanni Barillari, Elena Toschi, et al.
Vaccine|February 23, 2011
A combination HIV vaccine based on Tat and Env proteins was immunogenic and protected macaques from mucosal SHIV challenge in a pilot studyFlavia Ferrantelli, Maria Teresa Maggiorella, Ilaria Schiavoni, et al.
Vaccine|July 13, 2004
Novel biocompatible anionic polymeric microspheres for the delivery of the HIV-1 Tat protein for vaccine applicationAntonella Caputo, Egidio Brocca-Cofano, Arianna Castaldello, et al.
The Journal of Infectious Diseases|October 11, 2003
Sequence conservation and antibody cross-recognition of clade B human immunodeficiency virus (HIV) type 1 Tat protein in HIV-1-infected Italians, Ugandans, and South AfricansStefano Buttò, Valeria Fiorelli, Antonella Tripiciano, et al.
Pageof 7